| Q38621653 | Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma |
| Q37313694 | Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome |
| Q38947143 | Can the assessment of ABCB1 gene expression predict its function in vitro? |
| Q33267205 | Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression |
| Q34320121 | DNA and histone deacetylases as targets for neuroblastoma treatment |
| Q37834445 | Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma? |
| Q54563487 | Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma. |
| Q34256029 | Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation |
| Q39249745 | Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL. |
| Q36731122 | Iberin induces cell cycle arrest and apoptosis in human neuroblastoma cells. |
| Q33919243 | Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients |
| Q36303065 | In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog model |
| Q80045104 | MDR1 hypermethylation contributes to the progression of neuroblastoma |
| Q39450337 | Mechanisms of ellipticine-mediated resistance in UKF-NB-4 neuroblastoma cells |
| Q57906760 | Molecular biology of neuroblastoma |
| Q38702196 | Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. |
| Q37422646 | New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence. |
| Q36995742 | Polymorphic transporters and platinum pharmacodynamics |
| Q38985584 | Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma |
| Q35749321 | Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells |
| Q41869723 | Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs |
| Q37836006 | The connections between neural crest development and neuroblastoma |
| Q37360208 | Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment |